AFT Pharmaceuticals considers IPO, listing on NZX and ASX as it eyes international sales

Sophie Boot
Tue, 17 Nov 2015

By Sophie Boot Nov. 17 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based pharmaceutical company, is considering a $49 million initial public offering along with listing on the NZX and ASX. The proposed offer involves a primary raise of $45 million, and a $4 million selldown by the Atkinson Family Trust, which owns 87 percent of the company. AFT, which was founded in 1997, made a loss of $12.9 million for the year ended March 31, on revenue of $56.2 million. The company has achieved a compound annual growth rate in operating reve...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Finance FREE
Money Answers: what's the best share investing strategy in a recession?
Frances Cook | Sat, 02 Jul 2022

Spreading your money through good quality companies, then leaving it alone for a few years is the boring but most likely way to build wealth for most of us. 

On the Money
On The Money: Air NZ's feeding frenzy, Kerry Prendergast's movie date, and more
Pattrick Smellie | Sat, 02 Jul 2022

In this week's OTM: Greg Foran's preference for pies, Kerry Prendergast's future at the film commission, a blast from the past from Enable Networks, and more...

The Economist
The great Silicon Valley shake-out
The Economist | Sat, 02 Jul 2022

We look at the world’s startups and identify the safe, the uneasy and the doomed.

Digital innovation could shape the future of NZ

The digital age allows us to collaborate on some of our greatest scientific and environmental challenges

Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.